Header Logo

Connection

Okechinyere Achilonu to Drug Repositioning

Back to Details
This is a "connection" page, showing publications Okechinyere Achilonu has written about Drug Repositioning.
Okechinyere Achilonu
Connection Strength
0,045
Drug Repositioning
  1. Targeting the SARS-CoV-2 main protease using FDA-approved Isavuconazonium, a P2-P3 a-ketoamide derivative and Pentagastrin: An in-silico drug discovery approach. J Mol Graph Model. 2020 12; 101:107730.
    View in: PubMed
    Score: 0,045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.